Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Short Interest Down 16.5% in February

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) was the recipient of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 30,900 shares, a drop of 16.5% from the February 13th total of 37,000 shares. Based on an average daily trading volume, of 13,200 shares, the short-interest ratio is currently 2.3 days.

Algernon Pharmaceuticals Stock Performance

AGNPF stock opened at $0.07 on Wednesday. Algernon Pharmaceuticals has a 1 year low of $0.04 and a 1 year high of $0.12. The stock’s fifty day moving average price is $0.06 and its 200-day moving average price is $0.06.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.